| 产品编号 | CFN93292 | |
| CAS编号 | 83459-41-0 | |
| 分子式 = 分子量 | C58H98O26 = 1211.39 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Triterpenoids | |
| 植物来源 | The roots of Panax ginseng C. A. Mey. | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 人参皂苷Ra1 | CFN93292 | 83459-41-0 | 1mg | QQ客服:3004468087 |
| 人参皂苷Ra1 | CFN93292 | 83459-41-0 | 5mg | QQ客服:3004468087 |
| 人参皂苷Ra1 | CFN93292 | 83459-41-0 | 10mg | QQ客服:3004468087 |
| 人参皂苷Ra1 | CFN93292 | 83459-41-0 | 20mg | QQ客服:3004468087 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Ginsenoside Ra1 shows significant inhibitory effects on protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation (H/R). | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 0.8255 mL | 4.1275 mL | 8.255 mL | 16.51 mL | 20.6374 mL |
| 5 mM | 0.1651 mL | 0.8255 mL | 1.651 mL | 3.302 mL | 4.1275 mL |
| 10 mM | 0.0825 mL | 0.4127 mL | 0.8255 mL | 1.651 mL | 2.0637 mL |
| 50 mM | 0.0165 mL | 0.0825 mL | 0.1651 mL | 0.3302 mL | 0.4127 mL |
| 100 mM | 0.0083 mL | 0.0413 mL | 0.0825 mL | 0.1651 mL | 0.2064 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 11-羟基胡蔓藤碱乙; 11-Hydroxyhumantenine | CFN97998 | 122590-04-9 | C21H26N2O4 = 370.5 | 5mg | QQ客服:3004468091 |
| O-去甲基荷叶碱 ; O-Nornuciferine | CFN96770 | 3153-55-7 | C18H19NO2 = 281.35 | 5mg | QQ客服:3004468520 |
| 柚皮苷 4'-葡萄糖苷; Naringin 4'-glucoside | CFN95014 | 17257-21-5 | C33H42O19 = 742.7 | 5mg | QQ客服:3004468088 |
| 4,9-二羟基-alpha-拉帕醌; 4,9-Dihydroxy-alpha-lapachone | CFN98947 | 56473-67-7 | C15H14O5 = 274.3 | 5mg | QQ客服:3004468520 |